Cerevel Therapeutics Hldg Inc (CERE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2022 | 09-2022 | 06-2022 | 03-2022 | 12-2021 | |
| Operating Expenses | 107,247 | 95,065 | 93,006 | 72,530 | 64,490 |
| Operating Income | -107,247 | -95,065 | -93,006 | -72,530 | -64,490 |
| Interest Expense | 2,632 | 1,286 | 0 | 0 | 0 |
| Other Income | 17,231 | -3,587 | 2,535 | 4,236 | 5,435 |
| Pre-tax Income | -92,648 | -99,938 | -90,471 | -68,294 | -59,055 |
| Net Income Continuous | -92,808 | -99,938 | -90,471 | -68,294 | -59,055 |
| Net Income | $-92,808 | $-99,938 | $-90,471 | $-68,294 | $-59,055 |
| EPS Basic Total Ops | -0.59 | -0.66 | -0.61 | -0.46 | -0.40 |
| EPS Basic Continuous Ops | -0.60 | -0.66 | -0.61 | -0.46 | -0.40 |
| EPS Diluted Total Ops | -0.59 | -0.66 | -0.61 | -0.46 | -0.40 |
| EPS Diluted Continuous Ops | -0.60 | -0.66 | -0.61 | -0.46 | -0.40 |
| EPS Diluted Before Non-Recurring Items | -0.59 | -0.66 | -0.61 | N/A | N/A |
| EBITDA(a) | $-111,575 | $-95,736 | $-91,324 | $-70,859 | $-63,381 |